Liste des consensus et des lignes directrices sur la surveillance thérapeutique des médicaments biologiques

PaysTitre
Greuter T et al Therapeutic Drug Monitoring to guide clinical decision making in Inflammatory Bowel Disease patients with loss of response to ANTI-TNFs: a delphi technique-based consensus Digestion. 2019 Aug 28:1-9
Ooi CJ et al. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia Intest Res,May 31, 2019
Papamichael K. et al. Appropriate Therapeutic drug Monitoring of Biologics Agents for patients with inflammatory Bowel diseases Clinical Gastroenterology and Hepatology, 24 March 2019
Khan A et al. New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease N Z Med J. 2019 Mar 8;132(1491):46-62
Turner D et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline J Pediatr Gastroenterol Nutr. 2018 May 30.
Turner D et al. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline J Pediatr Gastroenterol Nutr. 2018 May 30.
Maaser C. et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications Journal of Crohn’s and Colitis, 2018, 1–32
Lichtenstein G. R et al. Clinical Guideline: Management of Crohn’s Disease in Adults Am J Gastroenterol 2018; 113:481–517
Mitrev  N. et al. Consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053.
Vande Casteele N. et al. Therapeutic Drug Monitoring in Inflammatory Bowel Disease Gastroenterology. 2017;153(3):835-857.e6.
Peyrin-Biroulet L et al. French National Consensus Clinical Guidelines for the Management of CD Dig Liver Dis. 2017; 49(4):368-377
Magro F et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Ulcerative Colitis J Crohns Colitis. 2017; 11(6):649-670.
Harbord M et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease J Crohns Colitis. 2017; 11(1):3-25
Peyrin-Biroulet L. et al.French National Consensus Clinical Guidelines for the Management of Ulcerative Colitis Dig Liver Dis. 2016; 48(7):726-33
Diagnostics Guidance [DG22] on Therapeutic monitoring of TNF-alpha Inhibitors in Crohn’s Disease https://www.nice.org.uk/guidance/dg22/chapter/1-Recommendations
A Hillary Steinhart et al. Clinical Practice Guidelines for the Medical Management of Non-hospitalized Ulcerative Colitis Gastroenterology. 2015; 148(5):1035-1058.e3.
F M Ruemmele et al. Consensus Guidelines of ECCO/ESPGHAN on the Medical Management of Pediatric Crohn’s Disease J Crohns Colitis. 2014;8(10):1179-207.